Cross Country Healthcare, Inc. CCRN
Set alert
13.25 USD 0.00 0.00%
At close · Jul 20
13.22 -0.03 -0.23%
After hours · Jul 20, 4:00 PM ET
13.24 Day range 13.26
7.43 52-week range 13.27
- YTD
- +63.58%
- 1 year
- +1.07%
- Open
- 13.26
- Prev close
- 13.25
- Mkt cap
- 428.06M
- Vol
- 1.78M
- Avg vol
- 644.88K
- EPS
- -3.05
- P/E
- 143.24
- Div yield
- 0.00%
More statistics
- Low
- 13.24
- High
- 13.26
- Forward P/E
- 30.34
- Beta
- 0.65
- Short ratio
- 4.65
- Inst. own
- 110.21%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 13.07
- 200-d avg
- 14.84
- 1y target
- 17.46
Analyst view
Consensus: hold
Hold
Price target (mean) 17.46 +31.8% upside
Now 13.25
- Target (low)
- 14.00
- Target (mean)
- 17.46
- Target (high)
- 18.61
Ratings (0m) 8 0 buy · 8 hold · 0 sell
- Strong buy0
- Buy0
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.12073 | 0.11 – 0.15 | 0.29 | -58.4% | 306.17M | -26.0% | 8 |
| Next quarter | 0.11058 | 0.06 – 0.20 | 0.19 | -41.8% | 304.95M | -19.6% | 6 |
| Current year | 0.5332 | 0.51 – 0.54242 | 2.23 | -76.1% | 1.34B | -33.6% | 7 |
| Next year | 0.58988 | 0.38 – 0.79 | 0.5332 | +10.6% | 1.25B | -6.5% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | Barrington Research | Downgrade | Outperform | Market Perform |
| Dec 5, 2024 | Truist Securities | Maintained | Hold | Hold |
| Nov 7, 2024 | Benchmark | Maintained | Buy | Buy |
| Oct 21, 2024 | Truist Securities | Maintained | Hold | Hold |
| Aug 8, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 1, 2024 | Truist Securities | Maintained | Hold | Hold |
| May 6, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| May 2, 2024 | Benchmark | Maintained | Buy | Buy |
| Feb 27, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 22, 2024 | Truist Securities | Maintained | Hold | Hold |
| Feb 22, 2024 | Benchmark | Maintained | Buy | Buy |
| Dec 6, 2023 | JMP Securities | Initiated | — | Market Perform |
| Nov 30, 2023 | UBS | Initiated | — | Neutral |
| Nov 29, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 3, 2023 | Truist Securities | Maintained | Hold | Hold |
| Nov 3, 2023 | Jefferies | Downgrade | Buy | Hold |
| Oct 5, 2023 | Jefferies | Maintained | Buy | Buy |
| Aug 14, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 8, 2023 | Credit Suisse | Maintained | Neutral | Neutral |
| Jun 26, 2023 | William Blair | Initiated | — | Outperform |
| Jun 1, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| May 5, 2023 | Credit Suisse | Maintained | — | Neutral |
| May 2, 2023 | Truist Securities | Maintained | — | Hold |
| Mar 10, 2023 | Loop Capital | Initiated | — | Buy |
| Feb 23, 2023 | Benchmark | Maintained | — | Buy |
| Feb 23, 2023 | Credit Suisse | Maintained | — | Neutral |
| Nov 7, 2022 | Barrington Research | Maintained | — | Outperform |
| Oct 5, 2022 | Truist Securities | Downgrade | Buy | Hold |
| Sep 15, 2022 | Benchmark | Maintained | — | Buy |
| Jun 13, 2022 | Benchmark | Maintained | — | Buy |